Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design.

MLA

van den Bos, Willemien, et al. “Salvage Ablative Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design.” Urologic Oncology, vol. 33, no. 11, Nov. 2015, p. 495.e1-7. EBSCOhost, https://doi.org/10.1016/j.urolonc.2015.06.015.

APA

van den Bos, W., Muller, B. G., de Bruin, D. M., de Castro Abreu, A. L., Chaussy, C., Coleman, J. A., Finelli, A., Gill, I. S., Gross, M. E., Jenniskens, S. F. M., Kahmann, F., Laguna-Pes, M. P., Rastinehad, A. R., Simmons, L. A., Sulser, T., Villers, A., Ward, J. F., & de la Rosette, J. J. M. C. H. (2015). Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design. Urologic Oncology, 33(11), 495.e1-7. https://doi.org/10.1016/j.urolonc.2015.06.015

Chicago

van den Bos, Willemien, Berrend G Muller, Daniel M de Bruin, Andre Luis de Castro Abreu, Christian Chaussy, Jonathan A Coleman, Antonio Finelli, et al. 2015. “Salvage Ablative Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design.” Urologic Oncology 33 (11): 495.e1-7. doi:10.1016/j.urolonc.2015.06.015.